Research Research Research InterestDepartment Equipment & Facilities​Selected Publications Bispecific antibodies as powerful immunotherapeutic agents for urological cancers: Recent innovations based on preclinical and clinical evidence Read more Cell cycle dysregulation in cancer Read more Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial Read more Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohortwith high prevalence of concomitant cerebrovascular disease Read more Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition Read more Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy Read more Collagen deposition in lung parenchyma driven by depletion of interstitial Lyve-1+ macrophages prevents cigarette smoke-induced emphysema and loss of airway function Read more Regulating the regulators: long non-coding RNAs as autophagic controllers in chronic disease management Read more Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials Read more Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation Read more Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases Read more ARID1A is a coactivator of STAT5 that contributes to CD8+ T cell dysfunction and anti-PD-1 resistance in gastric cancer Read more « Previous 1 … 3 4 5 6 7 8 Next »
